Information was received from a healthcare professional (hcp) and a consumer regarding a patient receiving bupivacaine (20 mg/ml at 6.087 mg/day) and dilaudid (25 mg/ml at 7.608 mg/day) via an implanted pump.The patient¿s medical history included stomach surgery in (b)(6) 2018 for gi (gastrointestinal) blockage that was unrelated her infusion system.The indication for pump use was non-malignant pain.On (b)(6) 2018 the hcp called with the patient on a speaker phone.Per the patient, the pump shocked her a week before she had an mri 3 weeks ago.During the mri, her pump was vibrating, and they had to stop during the mri because of her pump.She thought medication was released (a potential bolus) because she felt loopy/not normal.Then last week, she was shocked in her house when moving from room to room and she thought it was radiating from the pump location.At the time of the report, the patient was still experiencing the vibration sensation.No further complications have been reported as a result of this event.
|